Heather Morel, MBA
Advertisement
Articles by Heather Morel, MBA
REMS programs in acute and chronic pain management continue to evolve to reduce risk associated with pain medications.
REMS programs in acute and chronic pain management continue to evolve to reduce risk associated with pain medications.
What each stakeholder needs to know about REMS in today's fast-paced climate.
Advertisement
Latest Updated Articles
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: March 24th 2011 | Updated:
The Changing Landscape of REMS in Pain ManagementPublished: November 18th 2011 | Updated:
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: October 12th 2010 | Updated:
- REMS in Pain Management
Published: December 5th 2011 | Updated:
- Risk Evaluation and Mitigation Strategies in the Specialty BioPharma Market
Published: December 5th 2011 | Updated:
- REMS in Pain Management
Published: November 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Can Close the Opioid Addiction Care Gap
2
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
3
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
